Pemetrexed/Cisplatin With or Without Bevacizumab in Brain Metastases From Non Squamous Non-small Cell Lung Cancer
Status:
Unknown status
Trial end date:
2020-06-01
Target enrollment:
Participant gender:
Summary
This is a multi-center phase II randomized controlled study to assess the efficacy of
Pemetrexed/cisplatin with or without Bevacizumab on patients with brain metastasis from
non-small cell lung cancer(NSCLC) harboring EGFR wild type by intracranial PFS(iPFS),also PFS
,DCR and OS.The side effect is evaluated as well.